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Abstract
In the 2020, COVID-19 pandemic disease created an havoc situation world 
widely and mainly caused by Severe Acute Respiratory Syndrome Coronavirus-2 
(SARS-CoV-2). It has been challenging task for researchers, scientists and medico-
pharmaceutical organisations to find out rapid and reliable diagnosis methods. 
Among the all testing services, a Reverse Transcription Polymerase Chain Reaction 
(RT-PCR) is the more accurate, rapid and authenticated molecular technique used 
for most of the diagnosis of major diseases. It has been a global priority to fix the 
rapid diagnosis method to combat against the pandemic COVID-19. Thus, the 
present chapter mainly focussing on the progress of RT-PCR method develop-
ment though various processes of data collection on isolation of whole genome 
sequence, its primer and method designing. In this scenario, India suddenly become 
the global leader for vaccine development and hence the challenges and RT-PCR 
kit development in India and rest of the world has been be discussed. World wide 
many Government and private agencies and industries have taken an initiative for 
diagnosis of SARS-CoV-2 hence this chapter also summarised the scope of RT-PCR 
to combat pandemic situation in future.
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1. Introduction
Coronavirus outbreak first case found in Wuhan, China in December 2019 
[1]. Further, it became a pandemic, affecting the whole world. On February 2020, 
World Health Organisation (WHO) announced an official name for Coronavirus 
spread disease as COVID-19 [2]. It primarily targets a respiratory system in humans, 
as the appearance of symptoms depends on the incubation period, which further 
relies on the patient’s age and the immune system [3].
SARS-CoV-2 as a public health emergency was declared by WHO and thereafter 
it became essential to find diagnostic tests for early detection and early treatment 
[4]. Normally the best way to detect any virus from the sample is its isolation and 
further confirmation by various molecular techniques. But Center for Diseases 
Control and Prevention (CDC) recommended not to isolate the SARS-CoV-2 as 
it is a new virus and this practices could be a risky approach and suggested to use 
patients sample directly for diagnosis [5]. Most of the diagnostic methods are 
molecular-based hence for diagnosis virus genome study become necessary. On 
January 2020 the ssRNA - 29870 bp whole sequence of SARS-CoV-2 was reported 
with GenBank accession number MN908947 [6, 7]. Thus, the basic information 
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of genome sequence helpful for molecular based detection method development 
specially Polymerase chain reaction (PCR) based methods.
Main focused was on PCR as it is a rapid detection method. Among that Reverse 
Transcription Polymerase Chain Reaction (RT-PCR) is the most commonly used 
and still be using the method as it is exactly showing the positive results with great 
-sensitivity. RT-PCR was said to be a gold-standard for testing coronavirus [8]. 
RT-PCR can detect the virus from throat, nasopharyngeal swab as well as from stool 
sample [9]. Early detection using PCR prove to be most sensitive way as negative 
sample cannot be ruled out. One cohort study found that patients even if not having 
any symptoms still may be the carrier for viruses thus RT-PCR can detect those 
at genetic level. Thus, it helps in prevention of nosocomial infection and further 
spread unknowingly [10].
Sample collection methods also affect the diagnosis results. Thus, WHO and 
CDC recommended the use of nylon, rayon or any synthetic fibre swabs for 
sample collection. But shortage of such swabs hammered the testing numbers. 
Hence, some researchers decided to study the effect of cotton tipped plastic 
swabs on PCR results and it found that no inhibition effect was seen on PCR [11]. 
Another method related to heating of sample known as Loop-mediated Isothermal 
Amplification (LAMP) this works by skipping the RNA extraction process. RNA 
RT-LAMP sensitivity found to be 97%, while specificity was 99% [12]. Study tried 
the three viral transmission medium heating treatments named as directly without 
additives, in a formamide-EDTA buffer and in a RNAsnap™ buffer. Basically, this 
method skips the RNA extraction process of RT-qPCR by replacing it with heat-
ing treatments thus reduces the time for the test and also gives the same result as 
normal RT-PCR protocol [13]. Similarly, in one study RNA extraction process was 
skipped and on that place RT-qPCR master mixes were used. Now this helps under 
such situation where reagent shortage occurs in hospitals. It also expanded the 
testing capacities [14]. Similar way direct RT-qPCR was used in one of the study 
found to be an alternative for classical method without RNA extraction [15]. But 
there are certain limitations in remote areas and portable diagnosis will be prefer-
able using mini PCR based diagnosis kits. One study combined the mini PCR and 
multi-well plate reader for convenient and portable diagnosis under pandemic 
situation [16].
As per the available RNA sequences and need of diagnosis method for  
COVID-19, several RNA extraction kits are available in the market. But due to 
pandemic situation and rising number of COVID patients, it was under short-
age. Thus, magnetic beads base RNA extraction methods were used by various 
researchers. Silica beads were found to yields RNA and comparable with com-
mercially available QIAcube viral RNA extraction kit which were determined 
by RT-qPCR and RT-LAMP [17]. Another study due to complexity of protocol 
was done, in which rather than using transport medium and RNA extraction it 
was decided to study the use of direct elution of swab and performing RT-qPCR. 
Elution of dry swabs were done directly in simple TE buffer and tested. Thus, this 
process simplifies the pre RT-qPCR preparation [18].
Commercial RT-PCR kits are already available in the market and few of them are 
manufactured by Altona Diagnostics (Hamburg, Germany), BGI (Shenzhen, China), 
CerTest Biotec (Zaragoza, Spain), KH Medical (Gyeonggi-do, Republic of Korea), 
Primer Design (Chandler’s Ford, UK), R-Biopharm AG (Darmstadt, Germany), and 
Seegene (Seoul, South Korea). All these kits are the best for detection without any 
cross-reactivity with another virus and hence can be used for regular diagnosis of 
SARS-CoV-2 [19]. But the limit of detection (LoD) of kits matters the quality. Earlier 
China National Medical Products Administration (NMPA) approved 6 PCR kits, 
but due to time shortage optimisation was not done so LoD might get affected. Thus 
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examination of LoD of this 6 PCR kits with real RNA of the virus was carried. All kits 
showed different LoD and the poorest LoDs has high chances of giving false negative 
results. The lab should confirm the performance of the kits and the utilise [20]. Some 
of the primers and probes for CoV detection has been shown in Table 1.
Currently, the RT-PCR test has a 95% specificity and 70% of the sensitivity 
rate [28, 29]. Self-collected saliva specimens was tested with 6 different molecular 
diagnostic tests like RTqPCR LDT, SARS-CoV-2 RAT, 3 direct RT-qPCR kits, and 
RT-LAMP and all tests showed a excellent results. Thus, based on these results, 
molecular diagnostic method has a great scope ahead [30]. Dr. Aneesh Mehta said 
that saliva test for coronavirus by PCR is the new type of diagnosis, as it is not 
invasive method but just spit is required as a sample [31]. This test is said to be a 
‘SalivaDirect’ test developed by a scientist of the Yale School of Public Health, 
authorised by Food and Drug Administration (FDA) [32].
Most countries have been used Indian Council of Medical Research (ICMR, 
India) suggested Rapid Antigen Test (RAT) which was available as a kit and direct 
antigen identification from nasal swab [33]. However several countries found 
that the negative findings by RAT were shown to be positive by RT-PCR. Thus, 
according to Dr. Balram Bhargava, Director of ICMR, the RAT was found to offer 
false-negative outcomes. One of the reports says that around 11% of people found 
negative by RAT in Delhi, after testing with RT-PCR found to be positive [34]. The 
Indian Health Ministry and ICMR provided a guideline to re-test the RAT tested 
negative patients and those who develop symptoms after a few days of the test by 
RT-PCR [35]. Until now, RT-PCR is the recommended test for all organisations and 
has been followed. Still, many experts are trying to carry out a number of inven-
tions and studies to make it simpler, more practical and more cost-effective for the 






















USA N3 gene Forward primer: GGGAGCCTTGAA TAC ACC AAA A
Reverse primer: TGTAGCACG ATTGCAGCATTG
Probe: FAM-AYCACATTGGCACCCGCA ATCCTG-BHQ1
[25]









Primers and probes recorded for SARS-CoV-2 real-time reverse transcription PCR assays.
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of PCR based diagnosis of SARs CoV-2 including current challenges of diagnosis, 
protocols and future prospects.
2. Challenges for SARs CoV-2 diagnosis
For treatment of SARs CoV-2, no vaccines is available but it was only the option 
left out to healthcare sectors that to prevent transmission as soon as possible [26]. So 
most the countries invested in isolation and detection [26]. The diagnosis of COVID-19 
was difficult as it shows symptoms similar to those of flu viruses, thus it was crucial to 
find the diagnosis as early as possible for management purpose [36]. One of the most 
important problems in analytical chemistry was highlighted by the COVID-19 pan-
demic outbreak: the discrepancies between the testing technique (TT) and the testing 
method (TM) are a common confusion in the clinical field. In addition to the research 
procedure, TT consists of many steps, such as the collection of specimens, their preser-
vation, storage, transport, labelling and distribution. Pre-test planning procedures for 
patients are also part of the process. Previously, these procedures, also known as pre-
analytical variables, have been identified as the key causes of laboratory testing errors. 
The most acceptable TT for the TM must be validated during the production of the TM 
for the identification of the target analyte; otherwise the analysis is performed within 
a wide range of analytical errors [37]. Successful detection of the virus also depends on 
time of testing, early or late detection, viral load, sample collection etc. [38].
Further challenge was during the false negative results. It is easy to understand 
and interpret a perfect test for a disease; the test would only be positive if the 
disease was present, and it would only be negative if it were absent. However, since 
all studies have false positives and false negative results, diagnostic tests are not 
flawless. Test results do not definitively state whether or not there is a disease (or 
virus). This does not mean that the test is not beneficial; it merely implies that the 
test results must be probabilistically tested on the basis of test output characteris-
tics, patient data, and disease prevalence [39]. To interpret the results of incomplete 
tests, two main metrics that characterise the test are needed: diagnostic sensitiv-
ity and diagnosis specificity [40]. At present, for commonly used SARS-CoV-2 
samples, there is minimal information on these values. To accurately interpret an 
incomplete test, the approximate probability that the person being evaluated has 
the disorder must also be considered [39].
The diagnosis was completely relied on two ways Molecular and serological 
testing as shown in Figure 1. Different test among these two categories was tried 
during a pandemic situation [41].
Currently, RT-PCR is commonly used method by many laboratories due to 
specificity and fast detection [40]. Some test commonly use for CoV detection has 
been shown in Table 2.
Figure 1. 
Two ways of COVID-19 diagnosis.
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3. Real-time RT-PCR basics
RT-PCR stands for real-time reverse transcription-polymerase chain reaction 
(RT-PCR). It is a technique use to determine the nucleic acid (DNA/RNA) from 
sample specifically from a virus or bacteria. Currently used for COVID-19 testing. 
It combines the reverse transcription of RNA into DNA It uses radioactive isotope 
marker or fluorescent dyes for detection of the targeted gene. It can detect genetic 
material from nose, throat, stool and sputum sample [45].
4. Real-time RT-PCR protocol
SARS-CoV-2 testing solely depends on patients’ health and concern, if the 
patient is getting some symptoms like cough, fever, headache or related, then the 
patient can personally take a test by visiting COVID center. If patient is already 
under medical treatment related to some other health issues, then doctor can 
recommend a COVID test to that patient for an early treatment. After that the 
most important part of RT-PCR covid testing is a collection of sample. It is most 
Tests Detection Sample Advantage Disadvantage Reference
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Diagnostic testing for SARS-CoV-2.
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Kits Company Country
Virus RNA Extraction kit
QIAamp DSP Viral RNA Mini Kit Qiagen Hong Kong, Japan, 
USA
QIAamp Viral RNA Mini Kit
Chemagic Viral DNA/RNA 300 Kit H96 PerkinElmer chemagen 
Technologie GmbH
Germany
SARS-CoV-2 Nucleic Acid Kit (RUO)
MagNA Pure 96 System Roche Germany
ANDiS Viral Nucleic RNA Auto Extraction & 
Purification Kit
3Dmed China





SuperScript III One-Step RT-PCR System with 
Platinum Taq DNA Polymerase
ThermoFisher USA
TaqMan Fast Virus 1-Step Master Mix
SuperScript III Platinum One-Step qRT-PCR Kit
TaqPath 1-Step RT-qPCR Master Mix, CG
QuantiTect Probe RT-PCR Kit Qiagen Japan
New Coronavirus Nucleic Acid Detection Kit PerkinElmer chemagen 
Technologie GmbH
Germany
Respiratory SARS-CoV-2 RT-PCR Panel Assay
SARS-CoV-2 Real-time RT-PCR Assay
EURORealTime™ SARS-CoV-2
Table 3. 
Virus extraction and detection kits.
important as if the sample is not collected properly, it can affect the result as seen in 
many research [46–48]. CDC has provided the protocol for sample collection and all 
labs are following this same. Along with that, instruction regarding virus isolation 
has been given, it is not suppose to be done by an unless it is performed in the BSL-3 
laboratory. Sample recommended for collection are nasopharyngeal (NP) and oro-
pharyngeal (OP) swab for RT-PCR [49]. An expert technician can collect the sample 
from the nose and throat of patient separately by using swab which is individually 
wrapped. Swab has to be made up of synthetic fiber like plastic or wire shafts. 
Technician has to follow certain rules while collecting sample like 6 feet of separa-
tion, personal protective equipment (PPE) kit, proper gloves and faced covered lid. 
The sample is to be collected deeply. Once collected it has to be transferred to viral 
transport medium (VTM). VTM is made up of 2% FBS, 100 μg/mL Gentamicin 
and 0.5 μg/mL Amphotericin B. Among this 3 ml of media is transferred to sterile 
screwed capped bottles in which swab is put and stored before further testing [50]. 
Sample can be stored at 2–8 °C for 72 hours only. If the sample has to be transported 
for a long distance, then it should be carried in icepack [51].
Once the sample has been collected, then next important and time consuming 
process is RNA extraction means purification of RNA samples. Most of RNA extrac-
tion kits are available in the market shown in Table 3, which can be used directly 
contain lysis buffer and other chemicals which will lyse the virus and RNA will get 
into solution. First, in order to release the genetic material, the patient’s sample is 
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mixed with a solution which lyses the cells. In order to purify RNA, inactivation of 
RNA activity, denaturation of nucleoprotein complexes and elimination of contam-
inating DNA and proteins must take place by (phenol which will attract the other 
protein and break it down, guanidine isothyocynate is also a protein denaturant, 
RNase inhibitors to inactivate the ribonuclease enzyme) [52]. The resulting cellular 
debris will then proceed to the RT-PCR stage with the extracted RNA. Further RNA 
purification is carried by using kit or by centrifugation and solid phase extrac-
tion by using column Centrifuge and spin column, which is to be placed in a clean 
collection tube to collect the supernatant and filtrate is discarded. Again, it has to be 
washed and centrifuge. Further by using elution buffer RNA is purified.
After purification of viral RNA, the next step is the preparation of the reac-
tion mixture for PCR amplification. In this step master mix has to be used which 
is premixed concentrated solution that consists of buffer, Reverse transcriptase 
enzyme nucleotide, forward primer, reverse primer, TaqMan probe, DNA poly-
merase. Finally, the RNA template to be added and mixed by pulse vortexing. 
Then load the reaction mixture into a PCR plate which generally contain 96 wells, 
allowing analysis of several samples at a time. Then place this plate in PCR machine 
(thermal cycler). Real time RT-PCR is used for detection of new Coronavirus 
2019 by amplification of target sequences in Rdrp genes, E gene and N gene. The 
choice of the target depends on primers and the probe sequences. The first step in 
RT-PCR is reverse transcription. The first strand complementary DNA synthesis is 
primed with the PCR reverse primer which hybridizes the complementary part of 
the virus RNA genome. Reverse transcriptase then add DNA nucleotides onto the 
3-prime end of the primer synthesizing DNA complementary of the viral RNA. 
Then denaturation takes place. Thus PCR consists of a series of cycles consisting 
of Denaturation, annealing and elongation. In cycle 1, DNA denaturation at 95 °C 
occurs. The next step at 58 °C allows the annealing of forward primer to comple-
mentary part of DNA. In elongation step, DNA polymerase synthesize a new strand 
complementary to the DNA template by adding nucleotides from the reaction 
mixture. In 2nd cycle, DNA denaturation form ssDNA, then annealing of primers 
Figure 2. 
RT-PCR methodological performance flowchart.
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and Taq-man probe to its complementary part of the target DNA. Taq-man probe 
consist of a fluorophore covalentaly attached to the 5′ end of oligonucleotide probe, 
the fluorescence is emitted by the fluorophore when is excited by the cyclers light 
source. Also, this probe consists of quencher at 3′ end. The close proximity of the 
reporter to the quencher prevents detection of its fluorescence. When polymerase 
reaches the Taqman probe its endogenous 5′ nuclease activity cleaves the probe, 
separating the dye from the quencher, with each cycle of PCR more dyes are 
released, resulting in an increase in fluorescence intensity proportionately to the 
amount of amplicon synthesized. For the fluorescence signal a tungsten-halogen 
lamp, an excitation filter, lens, emission filter and charged coupled device (CCD) 
camera are use which converts light into digital data. A flowchart of the protocol 
has shown in Figure 2 [24].
5. Recent development of RT-PCR for SARS-CoV-2 diagnosis
In addition to prevention methods (e.g., hygiene, social distance, isolation of 
infected individuals, and travel restriction), rigorous community infection testing 
is essential to track the transmission of the disease as well as educating public poli-
cies [53]. Nations that have implemented large research strategies at an early stage 
like South Korea, Vietnam, and New Zealand have been better able to restrict the 
spread of the disease. Tests should ideally be simple to sample and evaluate, precise, 
reliable, scalable and inexpensive. Often, point-of-care tests (POCT) based on 
antibodies match this definition. However, rapidly emerging epidemics due to novel 
viruses do not allow antibody-based tests to evolve in a timely manner [54]. Because 
of the simple adaptability to the nucleotide sequence of the target, viral load tests 
based on real-time, quantitative RT-PCR (referred to as RTqPCR) are thus an ideal 
test [55]. This RT-qPCR is currently a reliable test commonly used for the diagnosis 
of SARS-CoV-2 infected symptomatic and asymptomatic patients [56]. Several 
scientific and clinical institutions around the world have produced molecular assays 
to diagnose SARS-CoV-2 and have made RT-qPCR primers and sample sets available 
to the public [57].
As the genetic code of coronaviruses consists of RNA, its purification of the 
test samples is a crucial step in RT-qPCR protocols. Officially, institutions in some 
countries have suggested unique RNA isolation kits for SARSCoV-2 detection [57]. 
Various virus extraction and detections kits are available in market as shown in 
Table 3. The qRT-PCR has the benefits of high sensitivity, high precision, and a 
wide variety of sample types that can be use but there are however several factors 
that influence qRT-PCR outcomes, such as repeated washing, purification and 
separation of viral nucleic acids, which cause a substantial loss of nucleic acid and 
increase the risk of fragmentation and hydrolysis of nucleic acid; the number of 
virus replications below the qRT-PCR detection threshold would also cause false 
negative effects on the early stage of SARS-CoV-2 infection. So this problem was 
faced by many laboratories [58]. Some started focusing on RT-LAMP—reverse 
transcriptase loop-mediated isothermal amplification [59]. Other PCR, which was 
found to be more potent to detect low viral load was digital droplet PCR (ddPCR) 
as compared to qRT-PCR but due to limited availability ddPCR instrumentation and 
lab expertise mostly qRT-PCR is being used [60]. At this point, superior resources 
are concentrated in all parts of the country to reinforce scientific research. It is 
assumed that our ability to diagnose and treat patients with new coronavirus pneu-
monia will develop further with the enhancement and advancement of detection 
technology.
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6. Status in India
Collection of data at one place so that whole country population can refer this 
data at such a tough situation was a necessity so the Government of India has open 
an website -https://covid19cc.nic.in/ICMR/login.aspx, which has lots of information 
regarding testing centers, counting of RT-PCR tests and other antibody–antigen 
tests, current positive cases, available collection centers with their address contacts 
etc. Also aligned with ICMR, said to be Covid-19 sample collection management 
system for rapid antigen, antibody and RT-PCR tests. Lots of RT-PCR kits with 
variations, are manufactured in India has been shown in Table 4.
7. International status
RT-qPCR assays were already known, but development can lead to better 
results. Thus, one study was done by targeting two monoplex assays recom-
mended by WHO that was targeted on the envelope gene (E-Sarbeco) and RNA-
Dependant RNA Polymerase coding genes (RdRp-IP4). This was combined and 
test named as ‘Duo SARS-CoV-2 RT-qPCR assay’. As already lots of duo assays 
are commercially available, but this study was done to combine in-house assays. 
Can be used to reduce the chances of false negative results as it is dual assay 
[60]. As dual target assays are commercially available, developed specifically to 













Throat, nose swab https://rellife.com/
Dry Swab-Direct 
RT-PCR test
Centre for Cellular 
and Molecular 
Biology (CCMB)














Throat, nose swab https://mylabdiscoverysolutions.com/

















IIT Delhi Throat, nose swab https://home.iitd.ac.in/news-tea-
haritaki.php
RT-PCR kit CSIR-IICT Throat, nose swab https://iictindia.org/
Table 4. 
RT-PCR kit developed by Indian companies and sample requirement.
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target multiple sites in the viral genome, but mutation rates in virus found to be 
moderate which can cause problem with respect to results. Some of the tests were 
done by using ‘cobas SARS-CoV-2 E gene qRT-PCR’ but some failures were seen 
due to change in nucleotide at position 26340 of the SARS-CoV-2 gene. So the 
study was done to identify single nucleotide polymorphism in E gene of the virus. 
This includes the importance of study regarding mutations in the virus and thus 
to prevent false negative results [61]. The protocol provided by WHO mention 
the three assay that is to be performed: First line screening assay - E gene assay, 
Confirmatory assay - RdRp gene assay, and Additional confirmatory assay - N 
gene assay [24]. ‘Multiplex Real Time PCR’ was also use to find its efficacy for 
SARS-CoV-2 detection. Found to be rapid and accurate method for viral detection 
[62]. ‘Aus Diagnostics respiratory MT-PCR assay’ was also found to be reliable and 
sensitive [63]. Two ‘Single-tube nested (STN) real-time RT-PCR assays’ specifi-
cally targets RdRp/Hel and N genes, found to be 100% specific for detection of 
SARS-CoV-2 [64]. Even high cost assays were given preference during a pandemic 
situation like TaqMan-based real-time RT-qPCR which was not even accessible to 
lots of laboratories. So it was performed by using 2 methods that are SYBR green 
RT-qPCR and conventional PCR basically standardisation was done of this 2 
methods which is cost effective methods and found to give equal results as that of 
TaqMan-based real-time RT-qPCR [65].
COVID-19 diagnosis now done by one step RT-qPCR by using primers and 
probes which were developed at different institutes like China CDC, Charite 
(Germany), The University of Hong Kong, National Institute of Infectious 
Diseases in Japan (Japan NIID), National Institute of Health in Thailand 
(Thailand NIH) and US CDC which was announced by WHO [2, 24]. One study 
performed the analysis of primer-probe sets specifically targeting the N region 
and RdRp/Orf1 of SARS-CoV-2 by N-assay and RdRp/Orf1 Assays. Primer probe 
set for N-assay was N (China CDC), HKU-N (HKU), NIID_2019-nCOV_N (Japan 
NIID), WH-NIC N (Thailand NIH), and 2019-nCoV_N1, -N2, and -N3 (US CDC) 
and for RdRp/Orf1 Assay RdRp_SARSr (Charite), HKU-ORF1b-nsp14 (HKU), 
and ORF1ab (China CDC) primer probe set was studied. Results says that 
NIID_2019-nCOV_N” from the Japan NIID and “ORF1ab” from China CDC gave a 
good performance for RT-qPCR analysis without any cross-reactivity and non-
specific amplifications. This can be used for further diagnosis [66]. Sensitivity 
of PCR also depends on primer concentration, degeneration and multi target 
detection. Initial concentration of primer was 300-900 nM but as its concentra-
tion rises sensitivity also improves [67]. One study found that concentration upto 
400 nM rise the sensitivity [68]. Degenerate primers plays an important role 
with respect to diversity of SARS-CoV-2. While screening assays with a single 
target area are more prone to sequence differences than dual or triple-target 
assays for multi-target identification [67]. Other than this primer length, melting 
temperature, GC content and annealing temperature also affects the sensitivity 
of PCR assay [67]. One study attempted to deduce the specific patterns among 
SARS-CoV-2 isolates and accordingly primers were design targeted to nsp2 gene 
and further use for diagnosis of probe free real-time RT-PCR. Sensitive and rapid 
SARS-CoV-2-specific real-time RT-PCR assay COVID-19-nsp2 has therefore been 
developed [69]. In one research, the efficiency of three novel real-time reverse 
transcription-PCR (RT-PCR) assays targeting RNA-dependent RNA polymerase 
(RdRp)/helicase (Hel), spike (S) and nucleocapsid (N) SARS-CoV-2 genes was 
developed and compared. RNA polymerase (RdRp)/(Hel) assay found to be 
effective with no cross reactivity with other viruses among samples [27]. Some of 
the RT-PCR kits manufactured at International level along with sample require-
































Kit Name Company Country Sample required Website
1copy™ COVID-19 qPCR Multi Kit 1drop Inc. Korea Nasal swab http://www.1drop.co.kr/
ANDiS® SARS-CoV-2 RT-qPCR 
Detection Kit
3D Medicines United state Nasopharyngeal swab https://www.3dmedcare.com/covid/
CareStart™ COVID-19 MDx RT-PCR Access Bio, Inc. United state Nasopharyngeal swab, Oropharyngeal 
swab
https://carestart.com/
MOLgen SARSCoV2 Real Time RT 
PCR
Adaltis S.r.l. Italy Nasopharyngeal swabs, oropharyngeal 





LyteStar 2019-nCoV RT-PCR Kit 1.0 ADT Biotech Malaysia Nasopharyngeal swab, Oropharyngeal 
swab
http://adt-biotech.com/lytestartm-detection-kits/
AccuPower® SARS-CoV-2 Real-Time 
RT-PCR kit
BIONEER Corporation Philippines Sputum, nasopharyngeal swab, 
oropharyngeal swab
https://eng.bioneer.com/20-scv-2122.html
VIASURE SARS-CoV-2 S gene Real 
Time PCR Detection Kit adapted for 
BD MAX™ System
CerTest Biotec, S.L. Spain Respiratory samples https://www.certest.es/
Simplexa™ COVID-19 Direct 
RT-PCR Kit
DiaSorin Molecular, LLC United state Nasal swab, nasopharyngeal swab, nasal 
wash/aspirate, and BAL specimens
https://molecular.diasorin.com/us/kit/
simplexa-covid-19-direct-kit/
Quick SARS-CoV-2 rRT-PCR Kit Zymo Research Corp. United state Upper respiratory and lower respiratory 
sample
https://www.zymoresearch.com/
SARS-CoV-2 Nucleic Acid Detection 
Kit (PCR-Fluorescent Probe Method)





Flu A/Flu B Real-time Multiplex 
RT-PCR Kit
Zhuhai Haitai Biological 
Pharmaceutical Co., Ltd
China Upper respiratory and lower respiratory 
sample
http://www.zhhaitai.com/












Kit Name Company Country Sample required Website
COVID-19 ORF1ab/N Gene PCR 
Detection Kit
Xi’an Tianlong Science 
and Technology Co., Ltd
China Upper respiratory and lower respiratory 
sample
https://xi-an-tianlong.abraa.com/
Real time RT-PCR Kit for the 
detection of SARS-CoV-2
Suzhou BTA Biotech 
Co. Ltd
China Nasal swab, nasopharyngeal swab, nasal 
wash/aspirate, and BAL specimens
http://vosunbio.com/
LyoDx® A Freeze-Dried Real-Time 




Alameda Respiratory samples https://signaldt-biosystems-llc.hub.biz/




Taiwan Nasopharyngeal or oropharyngeal 
swabs
http://covid19.sbc-biotech.com/
RainSure COVID-19 dPCR Detection 
Kit (lab-based)
RainSure Scientific Co., 
Ltd
China Respiratory samples http://en.rainsurebio.com/
COVID-19 One-Step COVID-19 
RT-PCR Kit
Pishtaz Teb Diagnostics Iran Nasopharyngeal or oropharyngeal 
swabs
https://pishtazteb.com/en/pcr/
PerkinElmer® SARS-CoV-2 Realtime 
RT-PCR Assay
PerkinElmer Inc. United state Nasopharyngeal or oropharyngeal 
swabs
https://www.perkinelmer.com/
SARS-CoV-2 One-Step RT-PCR Kit, 
RdRp and N Genes, CE-IVD
NZYTech Portugal Nasal swab, nasopharyngeal swab, nasal 




COVID-19 TaqMan RT-PCR Kit (E/
RdRP genes) Dx
Norgen Biotek Corp Canada Saliva & Swab Samples https://norgenbiotek.com/
Table 5. 
RT-PCR kits developed by International companies and sample requirement.
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8. Future prospects of RT-PCR
PCR method was discovered in 1986 and since then the method is serving  medical 
sectors. In the future, as potential molecular diagnostic methods, PCR will play a 
significant role. Lots of PCR methods are already used in various research and medical 
fields, but as we know currently under this pandemic situation RT-PCR has turned out 
to be a boon in healthcare sectors. Lots of kits have been manufactured throughout 
the world with some or little variation, thus making it more sensitive, specific and less 
time consuming. One factor which essential under pandemic situation was a multiple 
sample analysis in one go [5]. Thus more focus on using portable POC systems, we can 
imagine the use of micro-fluidics doing concurrent multiple sample analysis. It is possi-
ble to analyse immunomagnetic exosomal RNA by using micro-fluidic systems RT-PCR 
said to be a Chip-based integrated real-time reverse transcription PCR platform [70]. 
Similar way chip-based RT-PCR digitally can quantify the mRNA in single cell [71].
Scalable, quick, and inexpensive diagnostics of COVID-19 by RT-PCR could 
help restrict the spread of SARS-CoV-2, saving lives as a result. RNA extraction, 
however, constitutes an obstacle to the scale-up of experiments. Thus, one research 
was done directly using the RT-PCR and heat inactivated sample and efficacy was 
tested. The study proved that is not necessary to carry RNA extraction testing. The 
study also suggests the use of standard protocols for RT-PCR and transport media 
by the whole world so the it will become easier to deal with future epidemics. Such 
RT-PCR said to be an hid RT-PCR (heat-inactivated direct RT-PCR). Sample collec-
tion and rather than using transport media, usage of lysis buffer is found to be more 
efficient as it will directly lys the sample and can be used in RT-PCR without a need 
of any RNA extraction kit [72].
As Coronaviridae family consist many RNA viruses which not only infect the 
humans but also animals, birds etc. [73]. If we look at the history of this family will 
see that it has been always serious when it started infecting like in 2002, Severe 
acute respiratory syndrome coronavirus (SARS-CoV) emerged, in 2012, Middle 
East respiratory syndrome coronavirus (MERS-CoV), in 2016, swine acute diar-
rhoea syndrome coronavirus (SADS-CoV) and the latest one which cause pandemic 
in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [74]. 
Among this SADS-CoV infects pigs while other infect humans [75]. This all was 
controlled well but current 2019 epidemic was beyond control due to lack of diag-
nosis, medicines and vaccine. For now after all efforts diagnosis for SARS-CoV-2 
has been found but as lots of virus under this family can emerge in future and which 
has already spread in past needed to be studied [76]. So one research was completely 
done to make a molecular diagnostic kit which can identify almost all CoVs, thus 
to diagnose easily any virus among this family in future [77]. They designed a 
semi-nested RT-PCR based upon 38 genome sequences that has been recorded from 
human and animal CoVs. Thus proved to be a great finding which can diagnose all 
available CoVs or which can emerge in future too [77].
Lots of research regarding RT-PCR has been done, PCR like nested PCR, ddPCR, 
two step RT-PCR is an advance and gives more accurate results but labs were not 
that equipped and it was not possible to set up everything under such pandemic 
situation. Hence if we think about future this all equipments and facilities have to 
be adopted by laboratory to deal with emerging epidemics [57].
9. Conclusion
SARs-CoV-2, originated from Wuhan, China and spread all over world, causing 
a pandemic situation which affected the whole world badly at economic, social, 
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medical level also. Initially it was very difficult to deal with virus as no diagnosis, 
treatment or vaccine was available, but after lots of efforts of researchers now we 
have a good diagnosis and control condition in regards spread of infection. Even 
vaccination has been started in almost all countries. As in the earlier period of pan-
demic, the diagnosis was the main factor to prevent the spread of the virus. So main 
focus was on a diagnostic that to on molecular diagnosis as it is more efficient and 
accurate way of detection. Currently use molecular method is RT-PCR also said to 
be a gold standard detection method. Lots of RT-PCR kits are now available in most 
of the countries with little modifications and approvals. The key point to be noticed 
before the laboratory experiments is the right reliable sampling. Nasopharyngeal 
and oropharyngeal swabs, which are safer for collection are recommended for 
screening or early detection. If we talk about a future of RT-PCR advancement in 
methods like nested PCR, ddPCR, two step RT-PCR have been already done, which 
is found to be more accurate, but lack of instrumentation and expertise have put 
it behind, but in future this thing has to be focused and implemented so that the 
world can deal with any future epidemic.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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